Abstract

New Drug: Nirsevimab for prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call